Gino Villetti

Corporate Preclinical R&D, Chiesi Farmaceutici S.p.A.

Affiliated withChiesi Farmaceutici S.p.A.

Research Area

Biography

Gino Villetti has not added Biography.
If you are Gino Villetti and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 14	2017
Publication title Cited by 20	2018

Other Publications

Article	Year
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist. Neuroreport\| PubMed ID: 12438928	2002
The protective effect of ganstigmine against amyloid beta 25-35 neurotoxicity on chicken cortical neurons is independent from the cholinesterase inhibition. Neuroscience letters\| PubMed ID: 12697278	2003
Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 12750440	2003
Mechanisms of action of CHF3381 in the forebrain. British journal of pharmacology\| PubMed ID: 12890713	2003
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice. American journal of Alzheimer's disease and other dementias\| PubMed ID: 15214201	2004
High throughput screening of beta-amyloid secretion inhibitors using homogenous time-resolved fluorescence. Combinatorial chemistry & high throughput screening\| PubMed ID: 15578936	2004
CHF3381, a novel antinociceptive agent, attenuates capsaicin-induced pain in rats. European journal of pharmacology\| PubMed ID: 16125167	2005
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion. Journal of medicinal chemistry\| PubMed ID: 16134939	2005
Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives. Bioorganic & medicinal chemistry\| PubMed ID: 16460950	2006
Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways. British journal of pharmacology\| PubMed ID: 16565730	2006
Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819). Journal of medicinal chemistry\| PubMed ID: 16913695	2006
Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. The Journal of biological chemistry\| PubMed ID: 17267402	2007
In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents. Pharmacological research\| PubMed ID: 17292621	2007
Formoterol and beclomethasone dipropionate interact positively in antagonising bronchoconstriction and inflammation in the lung. Pharmacological research\| PubMed ID: 17336541	2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1). Journal of medicinal chemistry\| PubMed ID: 17352462	2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2). Journal of medicinal chemistry\| PubMed ID: 17352463	2007
1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of ... The Journal of pharmacology and experimental therapeutics\| PubMed ID: 17895400	2007
CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's disease : JAD\| PubMed ID: 20164581	2010
Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology. Magma (New York, N.Y.)\| PubMed ID: 20386954	2010
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissu... FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 20720158	2010
The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice. Journal of Alzheimer's disease : JAD\| PubMed ID: 21321397	2011
Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax\| PubMed ID: 21460372	2011
Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie. Prion\| PubMed ID: 22453180	2012
In vivo imaging of transiently transgenized mice with a bovine interleukin 8 (CXCL8) promoter/luciferase reporter construct. PloS one\| PubMed ID: 22761878	2012
Receptor for advanced glycation end products contributes to postnatal pulmonary development and adult lung maintenance program in mice. American journal of respiratory cell and molecular biology\| PubMed ID: 23144333	2013
Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice. BMC neuroscience\| PubMed ID: 23560952	2013
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases. Journal of medicinal chemistry\| PubMed ID: 24400806	2014
Enlightened Mannhemia haemolytica lung inflammation in bovinized mice. Veterinary research\| PubMed ID: 24460618	2014
Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study. Pharmacology research & perspectives\| PubMed ID: 25505605	2014
CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration--in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a ... The Journal of pharmacology and experimental therapeutics\| PubMed ID: 25576073	2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 25576075	2015
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin. Journal of translational medicine\| PubMed ID: 26239109	2015
Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model. Journal of translational medicine\| PubMed ID: 26496719	2015
Assessment of asthmatic inflammation using hybrid fluorescence molecular tomography-x-ray computed tomography. Journal of biomedical optics\| PubMed ID: 26803669	2016
Anti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokines. Pharmacology research & perspectives\| PubMed ID: 26977295	2016
In vivo monitoring of lung inflammation in CFTR-deficient mice. Journal of translational medicine\| PubMed ID: 27468800	2016
Physiological, Biochemical, and Biophysical Characterization of the Lung-Lavaged Spontaneously-Breathing Rabbit as a Model for Respiratory Distress Syndrome. PloS one\| PubMed ID: 28060859	2017
Heterologous Matrix Metalloproteinase Gene Promoter Activity Allows In Vivo Real-time Imaging of Bleomycin-Induced Lung Fibrosis in Transiently Transgenized Mice. Frontiers in immunology\| PubMed ID: 28298912	2017
Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice. Multidisciplinary respiratory medicine\| PubMed ID: 28400960	2017
The PDE4 inhibitor CHF-6001 and LAMAs inhibit bronchoconstriction-induced remodelling in lung slices. American journal of physiology. Lung cellular and molecular physiology\| PubMed ID: 28596292	2017
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases. Journal of medicinal chemistry\| PubMed ID: 29200281	2017